Jiangzhou Ji

639 total citations
9 papers, 369 citations indexed

About

Jiangzhou Ji is a scholar working on Molecular Biology, Cancer Research and Artificial Intelligence. According to data from OpenAlex, Jiangzhou Ji has authored 9 papers receiving a total of 369 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Cancer Research and 2 papers in Artificial Intelligence. Recurrent topics in Jiangzhou Ji's work include Circular RNAs in diseases (3 papers), Cancer-related molecular mechanisms research (3 papers) and MicroRNA in disease regulation (3 papers). Jiangzhou Ji is often cited by papers focused on Circular RNAs in diseases (3 papers), Cancer-related molecular mechanisms research (3 papers) and MicroRNA in disease regulation (3 papers). Jiangzhou Ji collaborates with scholars based in China. Jiangzhou Ji's co-authors include Peng Yang, Chaofan Peng, Chi Jin, Jiahui Zhou, Yuqian Tan, Tuo Wang, Qingyang Sun, Yueming Sun, Yifei Feng and Junwei Tang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Oncogene and IEEE Access.

In The Last Decade

Jiangzhou Ji

9 papers receiving 368 citations

Peers

Jiangzhou Ji

MB

CR

ONCOL

PRM

EPIDE

Qingyang Sun China

Guihong Zhang China

Yao‐Jie Pan China

Yue Du China

Wanrong Wu China

Mathilde Savall France

Zongjiang Luo China

Min Hong China

Ramiro J. Vicente-Blanco Spain

Guangcheng Guo China

Qingyang Sun China

Jiangzhou Ji

254 ×0.8

MB

143 ×0.7

CR

66 ×1.1

ONCOL

24 ×0.9

PRM

12 ×0.6

EPIDE

Citations per year, relative to Jiangzhou Ji Jiangzhou Ji (= 1×) peers Qingyang Sun

Countries citing papers authored by Jiangzhou Ji

Since Specialization

Citations

This map shows the geographic impact of Jiangzhou Ji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiangzhou Ji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiangzhou Ji more than expected).

Fields of papers citing papers by Jiangzhou Ji

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiangzhou Ji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiangzhou Ji. The network helps show where Jiangzhou Ji may publish in the future.

Co-authorship network of co-authors of Jiangzhou Ji

This figure shows the co-authorship network connecting the top 25 collaborators of Jiangzhou Ji. A scholar is included among the top collaborators of Jiangzhou Ji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiangzhou Ji. Jiangzhou Ji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Tang, Junwei, Wen Peng, Jiangzhou Ji, et al.. (2023). GPR176 Promotes Cancer Progression by Interacting with G Protein GNAS to Restrain Cell Mitophagy in Colorectal Cancer. Advanced Science. 10(12). e2205627–e2205627. 28 indexed citations

2.

Yang, Peng, Dongsheng Zhang, Tuo Wang, et al.. (2022). CAF-derived exosomal WEE2-AS1 facilitates colorectal cancer progression via promoting degradation of MOB1A to inhibit the Hippo pathway. Cell Death and Disease. 13(9). 796–796. 39 indexed citations

3.

Wang, Tuo, Chi Jin, Peng Yang, et al.. (2022). UBE2J1 inhibits colorectal cancer progression by promoting ubiquitination and degradation of RPS3. Oncogene. 42(9). 651–664. 26 indexed citations

4.

Jin, Chi, Tuo Wang, Dongsheng Zhang, et al.. (2022). Acetyltransferase NAT10 regulates the Wnt/β-catenin signaling pathway to promote colorectal cancer progression via ac4C acetylation of KIF23 mRNA. Journal of Experimental & Clinical Cancer Research. 41(1). 345–345. 103 indexed citations

5.

Liu, Hongyi, et al.. (2022). CMB AI Lab at SemEval-2022 Task 11: A Two-Stage Approach for Complex Named Entity Recognition via Span Boundary Detection and Span Classification. 1603–1607. 3 indexed citations

6.

Peng, Chaofan, Yuqian Tan, Peng Yang, et al.. (2021). Circ-GALNT16 restrains colorectal cancer progression by enhancing the SUMOylation of hnRNPK. Journal of Experimental & Clinical Cancer Research. 40(1). 272–272. 40 indexed citations

7.

Zhou, Jiahui, Lu Wang, Qingyang Sun, et al.. (2021). Hsa_circ_0001666 suppresses the progression of colorectal cancer through the miR‐576‐5p/PCDH10 axis. SHILAP Revista de lepidopterología. 11(11). e565–e565. 81 indexed citations

8.

Wang, Lu, Jiahui Zhou, Chuan Zhang, et al.. (2021). A novel tumour suppressor protein encoded by circMAPK14 inhibits progression and metastasis of colorectal cancer by competitively binding to MKK6. SHILAP Revista de lepidopterología. 11(10). e613–e613. 47 indexed citations

9.

Liu, Yongsheng, et al.. (2020). WALLACE: Weakly Supervised Learning of Deep Convolutional Neural Networks With Multiscale Evidence. IEEE Access. 8. 20449–20458. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact